Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart’s Top Stock Pick. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Omega Therapeutics Inc (OMGA)

Omega Therapeutics Inc (OMGA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Omega Therapeutics Inc 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 USA

P: 617-949-4360

Description:

Omega Therapeutics Inc. is a development-stage biotechnology company. Its OMEGA Epigenomic Programming(TM) platform harness the power of epigenetics to develop a new class of DNA-sequence-targeting, mRNA-encoded programmable epigenetic medicines. Omega Therapeutics Inc. is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 372,380
Enterprise Value, $K 166,920
Shares Outstanding, K 48,049
Annual Sales, $ 140 K
Annual Net Income, $ -68,280 K
Last Quarter Sales, $ 600 K
Last Quarter Net Income, $ -25,800 K
60-Month Beta 0.59
% of Insider Shareholders 60.00%
% of Institutional Shareholders 88.69%
Float, K 19,220
% Float 40.00%
Short Volume Ratio 0.52

Growth:

1-Year Return -29.45%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.54 on 11/08/22
Next Earnings Date 03/09/23
Earnings Per Share ttm -1.94
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 5.26%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

OMGA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -55.11%
Return-on-Assets % -45.58%
Profit Margin % -48,771.43
Net Margin % N/A
Debt/Equity 0.15
Price/Sales 250.27
Price/Cash Flow N/A
Price/Book 2.79
Book Value/Share 2.79
Interest Coverage -74.03
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar